Diversion of HIV-1 Vaccine-induced Immunity by gp41-Microbiota Cross-reactive Antibodies
Wilton Williams is a post-doctoral fellow working with Georgia Tomaras and Bart Haynes in the Duke Human Vaccine Institute. He is originally from Kingston, Jamaica, and received his doctorate from the University of Florida at Gainesville. His research focuses on HIV-1 immunobiology and vaccine development, and he has recently published (14Aug2015) a Science article on this research.
Resistance Patterns and Correlation to PMTCT Regimen in HIV-positive Infants in the Arusha and Kilimanjaro Regions of Tanzania
Annie Buchanan is a consulting associate in the department of pediatric infectious diseases at Duke. Her "real" job, however, is at ViiV Healthcare in RTP, where she serves as Physician Project Lead for the Dolutegravir Pediatric Program. Prior to this she spent 5 years in Tanzania at the Duke clinical research site in Moshi, first as a fellow and later as a junior faculty member. She is originally from Raleigh and has degrees from NC State, and UNC Chapel Hill, as well as doing her Peds ID fellowship at Duke.
Structure Based Methods to Target HIV-1 Transactivation Response Element RNA
Laura Ganser is a third year graduate student in the laboratory of Dr. Hashim Al-Hashimi in the Biochemistry department. Her research interests are studying the structure and function of RNA with a focus on developing strategies to target RNA with small molecules. She is particularly interested in characterizing transient conformations of the HIV-1 TAR RNA and developing their potential as a drug target.